Tinea Corporis: Multimedia

References

1. Adams BB. Tinea corporis gladiatorum. J Am Acad Dermatol. Aug 2002;47(2):286-90. [Medline].

2. Sun PL, Ho HT. Concentric rings: an unusual presentation of tinea corporis caused by Microsporum gypseum. Mycoses. Mar 2006;49(2):150-1. [Medline].

3. Sánchez-Castellanos ME, Mayorga-Rodríguez JA, Sandoval-Tress C, Hernández-Torres M. Tinea incognito due to Trichophyton mentagrophytes. Mycoses. Jan 2007;50(1):85-7. [Medline].

4. Kim HS, Cho BK, Oh ST. A case of tinea corporis purpurica. Mycoses. Jul 2007;50(4):314-6. [Medline].

5. Shiraki Y, Hiruma M, Matsuba Y, Kano R, Makimura K, Ikeda S, et al. A case of tinea corporis caused by Arthroderma benhamiae (teleomorph of Tinea mentagrophytes) in a pet shop employee. J Am Acad Dermatol. Jul 2006;55(1):153-4. [Medline].

6. Placzek M, van den Heuvel ME, Flaig MJ, Korting HC. Perniosis-like tinea corporis caused by Trichophyton verrucosum in cold-exposed individuals. Mycoses. Nov 2006;49(6):476-9. [Medline].

7. Seyfarth F, Ziemer M, Gräser Y, Elsner P, Hipler UC. Widespread tinea corporis caused by Trichophyton rubrum with non-typical cultural characteristics--diagnosis via PCR. Mycoses. 2007;50 Suppl 2:26-30. [Medline].

8. Liebel F, Lyte P, Garay M, Babad J, Southall MD. Anti-inflammatory and anti-itch activity of sertaconazole nitrate. Arch Dermatol Res. Sep 2006;298(4):191-9. [Medline].

9. Leyden J. Pharmacokinetics and pharmacology of terbinafine and itraconazole. J Am Acad Dermatol. May 1998;38(5 Pt 3):S42-7. [Medline].

10. da Silva Barros ME, de Assis Santos D, Soares Hamdan J. Antifungal susceptibility testing of Trichophyton rubrum by E-test. Arch Dermatol Res. May 2007;299(2):107-9. [Medline].

11. Wingfield AB, Fernandez-Obregon AC, Wignall FS, Greer DL. Treatment of tinea imbricata: a randomized clinical trial using griseofulvin, terbinafine, itraconazole and fluconazole. Br J Dermatol. Jan 2004;150(1):119-26. [Medline].

12. Aly R. Ecology and epidemiology of dermatophyte infections. J Am Acad Dermatol. Sep 1994;31(3 Pt 2):S21-5. [Medline].

13. Dahl MV. Dermatophytosis and the immune response. J Am Acad Dermatol. Sep 1994;31(3 Pt 2):S34-41. [Medline].

14. Del Rosso JQ, Draelos ZD, Jorizzo JL, Joseph WS, Ribotsky BM, Rich P. Modern methods to treat superficial fungal disease. Cutis. Feb 2007;79(2 Suppl):6-29. [Medline].

15. Drake LA, Dinehart SM, Farmer ER, Goltz RW, Graham GF, Hardinsky MK, et al. Guidelines of care for superficial mycotic infections of the skin: tinea corporis, tinea cruris, tinea faciei, tinea manuum, and tinea pedis. Guidelines/Outcomes Committee. American Academy of Dermatology. J Am Acad Dermatol. Feb 1996;34(2 Pt 1):282-6. [Medline].

16. Foster KW, Ghannoum MA, Elewski BE. Epidemiologic surveillance of cutaneous fungal infection in the United States from 1999 to 2002. J Am Acad Dermatol. May 2004;50(5):748-52. [Medline].

17. Gupta AK, Einarson TR, Summerbell RC, Shear NH. An overview of topical antifungal therapy in dermatomycoses. A North American perspective. Drugs. May 1998;55(5):645-74. [Medline].

18. Jones HE. Immune response and host resistance of humans to dermatophyte infection. J Am Acad Dermatol. May 1993;28(5 Pt 1):S12-S18. [Medline].

19. Lesher JL. Therapeutic agents for dermatologic fungal diseases. In: Elewski BE, ed. Cutaneous Fungal Infections. Malden: Blackwell Science; 1998:321-46.

20. Lesher JL Jr. Oral therapy of common superficial fungal infections of the skin. J Am Acad Dermatol. Jun 1999;40(6 Pt 2):S31-4. [Medline].

21. Macura AB. Dermatophyte infections. Int J Dermatol. May 1993;32(5):313-23. [Medline].

22. Piérard GE, Arrese JE, Piérard-Franchimont C. Treatment and prophylaxis of tinea infections. Drugs. Aug 1996;52(2):209-24. [Medline].

23. Rezabek GH, Friedman AD. Superficial fungal infections of the skin. Diagnosis and current treatment recommendations. Drugs. May 1992;43(5):674-82. [Medline].

24. Theos A. Diagnosis and management of superficial cutaneous fungal infections in children. Pediatr Ann. Jan 2007;36(1):46-54. [Medline].

25. Weinstein A, Berman B. Topical treatment of common superficial tinea infections. Am Fam Physician. May 15 2002;65(10):2095-102. [Medline].

26. Ziemer M, Seyfarth F, Elsner P, Hipler UC. Atypical manifestations of tinea corporis. Mycoses. 2007;50 Suppl 2:31-5. [Medline].

Further Reading

Keywords

ringworm, dermatophyte infection, Trichophyton species, Microsporum species, Epidermophyton species, Trichophyton rubrum, T rubrum, Microsporum canis, M canis, Trichophyton mentagrophytes, T mentagrophytes, Trichophyton tonsurans, T tonsurans, Trichophyton concentricum, T concentricum, Majocchi granuloma, Majocchi's granuloma, tinea imbricata, tinea capitis

Contributor Information and Disclosures

Author

Mary Elizabeth Rushing Lott, MD, Senior Resident, Department of Pediatrics, Miami Children's Hospital
Mary Elizabeth Rushing Lott, MD is a member of the following medical societies: Alpha Omega Alpha, American Medical Association, and American Medical Student Association/Foundation
Disclosure: Nothing to disclose.

Coauthor(s)

Gwendolyn Zember, MD, Consulting Staff, Department of Internal Medicine, University Hospital
Disclosure: Nothing to disclose.

Jack L Lesher Jr, MD, Chief, Professor, Department of Internal Medicine, Section of Dermatology, Medical College of Georgia
Jack L Lesher Jr, MD is a member of the following medical societies: American Academy of Dermatology, American Dermatological Association, American Medical Association, American Society for Dermatologic Surgery, Medical Association of Georgia, Society for Investigative Dermatology, and Southern Medical Association
Disclosure: Nothing to disclose.

Medical Editor

Janet Fairley, MD, Professor and Head, Department of Dermatology, University of Iowa
Janet Fairley, MD is a member of the following medical societies: American Academy of Dermatology, American Dermatological Association, American Federation for Medical Research, and Society for Investigative Dermatology
Disclosure: Nothing to disclose.

Pharmacy Editor

Richard P Vinson, MD, Assistant Clinical Professor, Department of Dermatology, Texas Tech University School of Medicine; Consulting Staff, Mountain View Dermatology, PA
Richard P Vinson, MD is a member of the following medical societies: American Academy of Dermatology, Association of Military Dermatologists, Texas Dermatological Society, and Texas Medical Association
Disclosure: Nothing to disclose.

Managing Editor

Rosalie Elenitsas, MD, Associate Professor of Dermatology, University of Pennsylvania School of Medicine; Director, Penn Cutaneous Pathology Services, Department of Dermatology, University of Pennsylvania Health System
Rosalie Elenitsas, MD is a member of the following medical societies: American Society of Dermatopathology
Disclosure: Nothing to disclose.

CME Editor

Joel M Gelfand, MD, MSCE, Medical Director, Clinical Studies Unit, Assistant Professor, Department of Dermatology, Associate Scholar, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania
Joel M Gelfand, MD, MSCE is a member of the following medical societies: Society for Investigative Dermatology
Disclosure: AMGEN Consulting fee Consulting; AMGEN Grant/research funds None; Genentech Consulting fee Consulting; Centocor Consulting fee Consulting; Centocor Grant/research funds None; Covance Consulting fee Consulting; Shire  Consulting

Chief Editor

Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center
Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.